GASTRIC ADENOCARCINOMA

This study is testing whether adding the immunotherapy drug pembrolizumab to standard chemotherapy and radiation improves outcomes for people with operable stomach cancer. It focuses on two specific types: cancers with mismatch repair deficiency or Epstein-Barr virus positivity. …

This study is comparing two treatment approaches for patients with a specific type of stomach or gastroesophageal junction cancer that has not spread widely. The goal is to see if using an immunotherapy drug (atezolizumab) combined with chemotherapy before and after surgery works…

This study is testing a new treatment approach for patients with stomach or gastroesophageal cancer that can be surgically removed. It combines two immunotherapy drugs (nivolumab and ipilimumab) with chemotherapy and radiation before surgery, aiming to shrink the tumor and help t…

This large Phase 3 trial is testing whether adding an experimental drug called ASKB589 to standard chemotherapy and immunotherapy works better for people with advanced stomach or gastroesophageal cancer. The study involves 780 patients in China who have a specific biomarker calle…

This study is testing whether adding a drug called tucatinib to standard cancer treatments is safe and effective for people with HER2-positive cancers of the digestive system, like stomach, colon, and gallbladder cancers. It involves about 40 participants who have advanced cancer…

This early-stage trial is testing whether a shorter, 2-week course of combined chemotherapy and radiation before surgery is safe and effective for patients with operable stomach cancer. The study involves 25 participants and compares this shorter approach to the standard 5-week t…

This study is testing a new approach to prevent stomach cancer from returning to the abdominal cavity after surgery. During the operation, doctors will wash the abdomen with a warm chemotherapy solution. The goal is to kill any stray cancer cells left behind to prevent the cancer…

This study is testing a special recovery plan for patients having surgery for stomach cancer. The plan aims to help patients feel better faster by reducing pain and nausea, helping their digestive system work again, and shortening their hospital stay. Researchers are following 52…

This study aims to understand if men and women in Germany receive different care for stomach cancer and if those differences affect survival. Researchers will analyze existing health records from 2017-2021 for about 75,000 people diagnosed with stomach cancer. The goal is to iden…